Correlation Between Zealand Pharma and FLSmidth

Can any of the company-specific risk be diversified away by investing in both Zealand Pharma and FLSmidth at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Zealand Pharma and FLSmidth into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Zealand Pharma AS and FLSmidth Co, you can compare the effects of market volatilities on Zealand Pharma and FLSmidth and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Zealand Pharma with a short position of FLSmidth. Check out your portfolio center. Please also check ongoing floating volatility patterns of Zealand Pharma and FLSmidth.

Diversification Opportunities for Zealand Pharma and FLSmidth

-0.67

Correlation Coefficient

Zealand Pharma  FLSmidth

Excellent diversification

The 3 months correlation between Zealand and FLSmidth is -0.67. Overlapping area represents the amount of risk that can be diversified away by holding Zealand Pharma AS and FLSmidth Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on FLSmidth and Zealand Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Zealand Pharma AS are associated (or correlated) with FLSmidth. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of FLSmidth has no effect on the direction of Zealand Pharma i.e., Zealand Pharma and FLSmidth go up and down completely randomly.

Pair Corralation between Zealand Pharma and FLSmidth

Assuming the 90 days trading horizon Zealand Pharma AS is expected to under-perform the FLSmidth. In addition to that, Zealand Pharma is 1.89 times more volatile than FLSmidth Co. It trades about -0.07 of its total potential returns per unit of risk. FLSmidth Co is currently generating about 0.16 per unit of volatility. If you would invest  32,600  in FLSmidth Co on September 4, 2024 and sell it today you would earn a total of  5,440  from holding FLSmidth Co or generate 16.69% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Zealand Pharma AS  vs.  FLSmidth Co

Zealand Pharma AS

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Zealand Pharma AS has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest unfluctuating performance, the Stock's basic indicators remain healthy and the recent disarray on Wall Street may also be a sign of long period gains for the firm investors.

FLSmidth

Risk-Adjusted Performance

12 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in FLSmidth Co are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating basic indicators, FLSmidth displayed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Zealand Pharma and FLSmidth

The main advantage of trading using opposite Zealand Pharma and FLSmidth positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Zealand Pharma position performs unexpectedly, FLSmidth can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in FLSmidth will offset losses from the drop in FLSmidth's long position.

The idea behind Zealand Pharma AS and FLSmidth Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.